Zobrazeno 1 - 10
of 1 175
pro vyhledávání: ''
Publikováno v:
Acta Ophthalmologica. 100:462-467
PURPOSE To investigate whether contact lenses used after surgery for congenital cataracts act as a depot for dexamethasone, which would allow the prescribed amount of drops to be reduced, and to examine whether the preservative benzalkonium chloride
Autor:
Miriam Kolko, Gianni Virgili, Anne Guldhammer Skov, Amalie Santaolalla Rives, Augusto Azuara-Blanco, Josefine Clement Freiberg
Publikováno v:
Acta Ophthalmologica. 100:253-261
Preservative-free topical medications have been introduced for glaucoma care to reduce ocular adverse events associated with preservatives. This is a systematic review and meta-analysis of randomized clinical trials (RCTs) comparing the efficacy and
Autor:
Sergio Recalde, Alfredo García-Layana, Patricia Fernandez-Robredo, Marta S. Figueroa, Lluís Arias Barquet, Manuel Saenz-de-Viteri, José García-Arumí, María Isabel López Gálvez
Publikováno v:
Acta Ophthalmologica. 99:861-870
To assess the effect of fluid status at baseline (BL) and at the end of the loading phase (LP) of three different ranibizumab regimens: treat-and-extend (TE), fixed bimonthly (FBM) injections and pro re nata (PRN), in patients with neovascular age-re
Autor:
Petteri Karesvuo, Laura Hakkala, Raimo Tuuminen, Kai Kaarniranta, Matti Ojamo, Hannu Uusitalo
Publikováno v:
Acta Ophthalmologica. 98:472-476
Purpose To correlate the rate of intravitreal anti-VEGF injections and the use of aflibercept as a second-line treatment with visual impairment throughout Finland. Methods Information related to anti-VEGF treatment, proportions of bevacizumab and afl
Autor:
Ayako Takahashi, Masayuki Hata, Akitaka Tsujikawa, Akihito Uji, Hiroshi Tamura, Naoko Ueda-Arakawa, Masahiro Miyake, Manabu Miyata, Yuki Mori, Yuichiro Shimizu, Sotaro Ooto, Kenji Yamashiro, Yuki Muraoka, Tomotaka Wakazono
Publikováno v:
Acta Ophthalmologica. 100
PURPOSE To investigate whether the efficacy of anti-vascular endothelial growth factor (VEGF) monotherapy for polypoidal choroidal vasculopathy (PCV) differs between pachychoroid and non-pachychoroid phenotypes in the long term. METHODS This retrospe
Autor:
Jan A. M. van Laar, Aniki Rothova, Josianne C E M ten Berge, Wishal D. Ramdas, Daphne P. C. Vergouwen
Publikováno v:
Acta Ophthalmologica, 100(3), e861-e863. Wiley-Blackwell Publishing Ltd
Autor:
Anders Tolstrup Christiansen, Kristian Klemp, Nina Buus Sørensen, Jens Folke Kiilgaard, Steffen Heegaard, Troels W. Kjaer, Morten la Cour, Karin Warfvinge
Publikováno v:
Sørensen, N B, Christiansen, A T, Kjaer, T W, Klemp, K, Cour, M L, Heegaard, S, Warfvinge, K & Kiilgaard, J F 2020, ' Loss of retinal tension and permanent decrease in retinal function : a new porcine model of rhegmatogenous retinal detachment ', Acta Ophthalmologica, vol. 98, no. 2, pp. 145-152 . https://doi.org/10.1111/aos.14188
Acta Ophthalmologica
Acta Ophthalmologica
PURPOSE: Permanent loss of visual function after rhegmatogenous retinal detachment can occur despite successful surgical reattachment in humans. New treatment modalities could be explored in a detachment model with loss of retinal function. In previo
Autor:
Liv Erngaard, Torben Lykke Sørensen, Troels Brynskov, Inger Christine Munch, Tobias Malte Larsen
Publikováno v:
Brynskov, T, Munch, I C, Larsen, T, Erngaard, L & Sørensen, T L 2020, ' Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration ', Acta Ophthalmologica, vol. 98, no. 2, pp. 132-138 . https://doi.org/10.1111/aos.14183
Brynskov, T, Munch, I C, Larsen, T M, Erngaard, L & Sørensen, T L 2020, ' Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration ', Acta Ophthalmologica, vol. 98, no. 2, pp. 132-138 . https://doi.org/10.1111/aos.14183
Brynskov, T, Munch, I C, Larsen, T M, Erngaard, L & Sørensen, T L 2020, ' Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration ', Acta Ophthalmologica, vol. 98, no. 2, pp. 132-138 . https://doi.org/10.1111/aos.14183
Purpose: To report 10-year, real-world experiences with intravitreal therapy (IVT) using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration (nAMD). Methods: Retrospective single-centre review of IVT-log 200
Autor:
Ketil Eriksen, Ragnheiður Bragadóttir, Øystein Kalsnes Jørstad, Leif Arthur Steffensen, Morten C. Moe
Publikováno v:
Acta Ophthalmologica. 98:774-779
Purpose To describe the first 13 years of anti‐vascular endothelial growth factor (anti‐VEGF) therapy from the perspective of a public ophthalmic department serving a local community of almost one million people. Methods Retrospective registry st
Publikováno v:
Acta Ophthalmologica. 98:36-42
Purpose To compare the efficacy, safety and tolerability of a single perioperative subconjunctival injection of triamcinolone acetonide (TA) with steroid drops for the prevention of macular oedema and ocular inflammation after cataract surgery. Metho